| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q6RG77 | Nuclear transcription factor Y subunit beta; CAAT box DNA-binding protein subunit B; Nuclear transcription factor Y subunit B; NF-YB; | NFYB; | NP_001075369.1; | 207 | horse |
| Q8HZQ3 | Antimicrobial peptide NK-lysin; | NKL; | NP_001075398.2; | 145 | horse |
| P48652 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; NADH dehydrogenase subunit 1; | MT-ND1; MTND1 NADH1 ND1; | NP_007160.1; | 318 | horse |
| P48653 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; NADH dehydrogenase subunit 2; | MT-ND2; MTND2 NADH2 ND2; | NP_007161.1; | 346 | horse |
| P48654 | NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3; NADH dehydrogenase subunit 3; | MT-ND3; MTND3 NADH3 ND3; | NP_007167.1; | 115 | horse |
| P48658 | NADH-ubiquinone oxidoreductase chain 4L; EC 1.6.5.3; NADH dehydrogenase subunit 4L; | MT-ND4L; MTND4L NADH4L ND4L; | NP_007168.1; | 98 | horse |
| P48655 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; NADH dehydrogenase subunit 4; | MT-ND4; MTND4 NADH4 ND4; | NP_007169.1; | 459 | horse |
| P48656 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; NADH dehydrogenase subunit 5; | MT-ND5; MTND5 NADH5 ND5; | NP_007170.1; | 604 | horse |
| P48657 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; NADH dehydrogenase subunit 6; | MT-ND6; MTND6 NADH6 ND6; | NP_007171.1; | 175 | horse |
| O18912 | Long-wave-sensitive opsin 1; Red cone photoreceptor pigment; Red-sensitive opsin; Fragment; | OPN1LW; RCP; | NULL | 273 | horse |
| P83005 | Osteocalcin; Bone Gla protein; BGP; Gamma-carboxyglutamic acid-containing protein; | BGLAP; | NULL | 49 | horse |
| P79892 | Cellular tumor antigen p53; Tumor suppressor p53; Fragment; | TP53; P53; | NULL | 280 | horse |
| P00594 | Phospholipase A2; EC 3.1.1.4; Group IB phospholipase A2; Phosphatidylcholine 2-acylhydrolase 1B; Fragment; [Cleaved into: Phospholipase A2 isoform 2]; | PLA2G1B; | NULL | 132 | horse |
| O77793 | Cytosolic phospholipase A2; cPLA2; Phospholipase A2 group IVA; EC 3.1.1.5; Phosphatidylcholine 2-acylhydrolase; EC 3.1.1.4; | PLA2G4A; CPLA2 PLA2G4; | NP_001075312.1; | 749 | horse |
| Q28389 | Pregnancy-associated glycoprotein; PAG; EC 3.4.23.-; | PAG; | NP_001075412.1; | 388 | horse |
| Q867C9 | ATP-dependent 6-phosphofructokinase, muscle type; ATP-PFK; PFK-M; EC 2.7.1.11; 6-phosphofructokinase type A; Phosphofructo-1-kinase isozyme A; PFK-A; Phosphohexokinase; | PFKM; | NP_001075391.1; | 780 | horse |
| O19183 | Prostaglandin G/H synthase 2; EC 1.14.99.1; Cyclooxygenase-2; COX-2; PHS II; Prostaglandin H2 synthase 2; PGH synthase 2; PGHS-2; Prostaglandin-endoperoxide synthase 2; | PTGS2; COX2; | NP_001075244.1; | 604 | horse |
| P00559 | Phosphoglycerate kinase 1; EC 2.7.2.3; | PGK1; PGK; | NULL | 417 | horse |
| Q8MIF7 | Phosphoglycerate kinase 2; EC 2.7.2.3; Phosphoglycerate kinase, testis specific; | PGK2; | NP_001077063.1; | 417 | horse |
| O46403 | Biglycan; Bone/cartilage proteoglycan I; PG-S1; | BGN; | NP_001075308.1; | 372 | horse |
